Multiple Ascending-Dose Study of XmAb®27564 in Patients With Psoriasis or Atopic Dermatitis

Summary

The purpose of this study is to evaluate the safety and tolerability of XmAb27564 following multiple doses among participants with plaque psoriasis and atopic dermatitis.

Timeline

Start

2022-10-10

Primary completion

2024-03-22

Completion

2024-11-22

Outcome

Outcome not reported

Stopped (Business): “Business Decision”

Drugs

Indications